Gastrointestinal Cancer News

Guardant360 — a liquid biopsy test through which next-generation sequencing is performed on cell-free DNA extracted from a patient’s blood — appeared effective for detection of microsatellite instability status, according to study data published in Clinical Cancer Research.

Higher pancreatic tail radiation doses during childhood cancer treatment appeared associated with higher risk for diabetes later in life, according to results of a prospective, survey-based study published in Journal of the National Cancer Institute.

Elderly patients with HIV and cancer appeared to have worse clinical outcomes than patients without HIV, according to results of a retrospective study published in JAMA Oncology.

The FDA approved pembrolizumab as monotherapy for certain patients with recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus.

CHICAGO —Modified FOLFOX chemotherapy plus active symptom control improved OS compared with active symptom control alone among patients with locally advanced or metastatic biliary tract cancer who were previously treated with cisplatin plus gemcitabine, according to results of the ABC-06 trial.

CHICAGO — An interim analysis of data from the phase 2 RAMIRIS trial suggests that a combination regimen of FOLFIRI plus ramucirumab is a feasible second-line treatment option for patients with advanced or metastatic gastroesophageal adenocarcinoma, according to researchers at the ASCO Annual Meeting.

CHICAGO — Administering chemotherapy 6 weeks before surgery for colon cancer was safe and reduced postoperative morbidity without adding to the cost or burden of treatment, according to recent findings from the FOxTROT trial.

Laura Dawson, MD, FASTRO, has been chosen as president-elect of American Society for Radiation Oncology.

Laura Dawson, MD, FASTRO, has been chosen as president-elect of American Society for Radiation Oncology.

The most effective and preferred treatment for many cancers remains surgery, and surgical techniques continue to evolve with the rest of the cancer care arsenal.